SEC Tracker
Get the app
Person · CIK 1991536

John Leite

Global Chief Commercial Off at Veracyte

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$2.1M
Noticed on Form 144$1.9M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Veracyte VCYTCommon StockDirectly124,329Sep 21, 2026 · Filing · EDGAR
Veracyte VCYTStock Option (right to buy)
exercise $19.81, expires Sep 1, 2032, into Common Stock
Directly43,044Sep 1, 2023 · Filing · EDGAR
Veracyte VCYTStock Option (right to buy)
exercise $23.73, expires Mar 6, 2033, into Common Stock
Directly25,268Sep 1, 2023 · Filing · EDGAR

Sold and noticed by quarter

John Leite: dollars sold on Form 4 and noticed on Form 144 per quarter, Q3 2024 to Q4 2026$700K$0Q3 2024: $195K noticed on Form 144Q3 2024: $195K sold on Form 4Q4 2024: $46K noticed on Form 144Q4 2024: $45K sold on Form 4Q1 2025: $241K noticed on Form 144Q1 2025: $429K sold on Form 4Q2 2025: $74K noticed on Form 144Q2 2025: $76K sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $278K noticed on Form 144Q4 2025: $290K sold on Form 4Q1 2026: $185K noticed on Form 144Q1 2026: $185K sold on Form 4Q2 2026: $680K noticed on Form 144Q2 2026: $700K sold on Form 4Q3 2026: $160K noticed on Form 144Q3 2026: $161K sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q3 2024Q1 2025Q3 2025Q1 2026Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q3 2026$161K$160K
Q2 2026$700K$680K
Q1 2026$185K$185K
Q4 2025$290K$278K
Q2 2025$76K$74K
Q1 2025$429K$241K
Q4 2024$45K$46K
Q3 2024$195K$195K

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Jun 9, 2026 · 1 notice
Sep 21, 20264,015 · ~$160KSep 21, 2026Sold as noticed Sold 4,015 at $40.00 on Sep 21 · $161K Form 4Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Jun 9, 2025 · 4 notices
Jun 4, 202613,975 · ~$680KJun 4, 2026Sold as noticed Sold 13,975 at $50.07 on Jun 4 · $700K Form 4Filing · EDGAR
Mar 4, 20265,260 · ~$185KMar 4, 2026Sold as noticed Sold 5,260 at $35.19 on Mar 4 · $185K Form 4Filing · EDGAR
Nov 25, 20254,086 · ~$191KNov 25, 2025Sold as noticed Sold 4,086 in 2 sales, Nov 25 to Dec 4 · $201K Form 4 (1) · Form 4 (2)Filing · EDGAR
Oct 1, 20252,539 · ~$87KOct 1, 2025Sold as noticed Sold 2,539 at $35.00 on Oct 1 · $89K Form 4Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 6, 2024 · 2 notices
Jun 4, 20252,809 · ~$74KJun 4, 2025Sold as noticed Sold 2,809 at $27.20 on Jun 4 · $76K Form 4Filing · EDGAR
Mar 7, 20257,411 · ~$241KMar 7, 2025Sold as noticed Sold 7,411 in 2 sales, Mar 7 to Mar 7 · $235K Form 4Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 1, 2024 · 3 notices
Dec 3, 20241,050 · ~$46KDec 3, 2024Sold as noticed Sold 1,050 at $43.25 on Dec 3 · $45K Form 4Filing · EDGAR
Sep 4, 20245,479 · ~$166KSep 4, 2024Sold as noticed Sold 5,479 at $29.78 on Sep 4 · $163K Form 4Filing · EDGAR
Jul 16, 20241,277 · ~$29KJul 16, 2024Sold as noticed Sold 1,277 at $25.00 on Jul 16 · $32K Form 4Filing · EDGAR
Sales without a matching Form 144 · 1 sale
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Veracyte (VCYT): Sold 5,746 at $33.84 on Feb 27, 2025 · $194KFiling · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Veracyte VCYT Global Chief Commercial Off · filings 2023 to 2026 · sold $2.1M · $1.9M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Sep 21, 2026Sale under a 10b5-1 plan−4,015$40.00$161K124,329 directFiling · EDGAR
Sep 2, 2026Shares withheld for tax or exercise price−3,961$44.88$178K128,344 directFiling · EDGAR
Jun 4, 2026Sale under a 10b5-1 plan−13,975$50.07$700K132,305 directFiling · EDGAR
Jun 2, 2026Shares withheld for tax or exercise price−4,059$47.80$194K146,280 directFiling · EDGAR
Mar 6, 2026Grant or award from the company+36,181143,761 directFiling · EDGAR
Mar 6, 2026Grant or award from the company+6,578150,339 directFiling · EDGAR
Mar 4, 2026Sale under a 10b5-1 plan−5,260$35.19$185K107,580 directFiling · EDGAR
Mar 2, 2026Shares withheld for tax or exercise price−7,517$36.01$271K112,840 directFiling · EDGAR
Feb 26, 2026Grant or award from the company+47,149129,262 directFiling · EDGAR
Feb 26, 2026Shares withheld for tax or exercise price−8,905$38.75$345K120,357 directFiling · EDGAR
Dec 4, 2025Sale under a 10b5-1 plan−1,278$47.51$61K82,113 directFiling · EDGAR
Dec 2, 2025Shares withheld for tax or exercise price−2,900$46.16$134K83,391 directFiling · EDGAR
Nov 25, 2025Sale under a 10b5-1 plan−2,808$50.00$140K86,291 directFiling · EDGAR
Oct 1, 2025Sale under a 10b5-1 plan−2,539$35.00$89K89,099 directFiling · EDGAR
Sep 2, 2025Shares withheld for tax or exercise price−2,902$30.11$87K91,638 directFiling · EDGAR
Jun 4, 2025Sale under a 10b5-1 plan−2,809$27.20$76K94,540 directFiling · EDGAR
Jun 2, 2025Shares withheld for tax or exercise price−2,900$26.74$78K97,349 directFiling · EDGAR
Mar 7, 2025Sale under a 10b5-1 plan−2,400$31.04$74K105,260 directFiling · EDGAR
Mar 7, 2025Sale under a 10b5-1 plan−5,011$31.96$160K100,249 directFiling · EDGAR
Mar 6, 2025Grant or award from the company+36,240107,660 directFiling · EDGAR
Mar 2, 2025Shares withheld for tax or exercise price−7,650$34.76$266K71,420 directFiling · EDGAR
Feb 27, 2025Grant or award from the company+11,00684,816 directFiling · EDGAR
Feb 27, 2025Open-market or private sale−5,746$33.84$194K79,070 directFiling · EDGAR
Dec 3, 2024Sale under a 10b5-1 plan−1,050$43.25$45K73,810 directFiling · EDGAR
Dec 2, 2024Shares withheld for tax or exercise price−1,314$44.12$58K74,860 directFiling · EDGAR
Sep 4, 2024Sale under a 10b5-1 plan−5,479$29.78$163K76,174 directFiling · EDGAR
Sep 2, 2024Shares withheld for tax or exercise price−1,315$31.55$41K81,653 directFiling · EDGAR
Jul 16, 2024Sale under a 10b5-1 plan−1,277$25.00$32K82,968 directFiling · EDGAR
Jun 2, 2024Shares withheld for tax or exercise price−1,314$20.75$27K84,245 directFiling · EDGAR
Mar 6, 2024Grant or award from the company+49,88085,559 directFiling · EDGAR
Mar 2, 2024Shares withheld for tax or exercise price−3,008$24.00$72K35,679 directFiling · EDGAR
Dec 2, 2023Shares withheld for tax or exercise price−556$26.54$15K38,687 directFiling · EDGAR
Sep 2, 2023Shares withheld for tax or exercise price−2,222$26.70$59K39,243 directFiling · EDGAR
All 35 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Sep 22, 2026Form 4Veracyte VCYTFiling · EDGAR
Sep 21, 2026Form 144Veracyte VCYTFiling · EDGAR
Sep 4, 2026Form 4Veracyte VCYTFiling · EDGAR
Jun 4, 2026Form 4Veracyte VCYTFiling · EDGAR
Jun 4, 2026Form 144Veracyte VCYTFiling · EDGAR
Mar 10, 2026Form 4Veracyte VCYTFiling · EDGAR
Mar 6, 2026Form 4Veracyte VCYTFiling · EDGAR
Mar 4, 2026Form 4Veracyte VCYTFiling · EDGAR
Mar 4, 2026Form 144Veracyte VCYTFiling · EDGAR
Mar 2, 2026Form 4Veracyte VCYTFiling · EDGAR
Dec 4, 2025Form 4Veracyte VCYTFiling · EDGAR
Nov 26, 2025Form 4Veracyte VCYTFiling · EDGAR
Nov 25, 2025Form 144Veracyte VCYTFiling · EDGAR
Oct 3, 2025Form 4Veracyte VCYTFiling · EDGAR
Oct 1, 2025Form 144Veracyte VCYTFiling · EDGAR
Sep 4, 2025Form 4Veracyte VCYTFiling · EDGAR
Jun 6, 2025Form 4Veracyte VCYTFiling · EDGAR
Jun 4, 2025Form 144Veracyte VCYTFiling · EDGAR
Jun 4, 2025Form 4Veracyte VCYTFiling · EDGAR
Mar 10, 2025Form 4Veracyte VCYTFiling · EDGAR
Mar 7, 2025Form 144Veracyte VCYTFiling · EDGAR
Mar 3, 2025Form 4Veracyte VCYTFiling · EDGAR
Dec 4, 2024Form 4Veracyte VCYTFiling · EDGAR
Dec 3, 2024Form 144Veracyte VCYTFiling · EDGAR
Sep 6, 2024Form 4Veracyte VCYTFiling · EDGAR
Sep 4, 2024Form 144Veracyte VCYTFiling · EDGAR
Sep 4, 2024Form 4Veracyte VCYTFiling · EDGAR
Jul 18, 2024Form 4Veracyte VCYTFiling · EDGAR
Jul 16, 2024Form 144Veracyte VCYTFiling · EDGAR
Jun 4, 2024Form 4Veracyte VCYTFiling · EDGAR
Mar 8, 2024Form 4Veracyte VCYTFiling · EDGAR
Mar 5, 2024Form 4Veracyte VCYTFiling · EDGAR
Dec 5, 2023Form 4Veracyte VCYTFiling · EDGAR
Sep 6, 2023Form 4Veracyte VCYTFiling · EDGAR
Sep 6, 2023Form 3Veracyte VCYTFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.